CDT CDT Equity Inc.
Healthcare$1.05-13.93%ClosedMarket Cap: $5.1M
As of 2026-05-25
Valuation
View DetailsP/E (TTM)
0.00
PEG
0.00
P/B
0.03
P/S
0.01
EV/EBITDA
13.52
DCF Value
$1,690,601.09
FCF Yield
-116.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
36.9%
Operating Margin
6.4%
Net Margin
2.4%
ROE
2.6%
ROA
0.5%
ROIC
0.9%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $696.4M | $51.0M | $— |
| Q4 null | $0.00 | $-21.3M | $— |
| FY null | $2.72B | $237.5M | $— |
| Q3 null | $0.00 | $-7.1M | $— |
Trading Activity
Insider Trades
View AllRegan Andrewdirector, officer: Chief Executive Officer
SellThu May 14
Regan Andrewdirector, officer: Chief Executive Officer
SellThu May 14
Regan Andrewdirector, officer: Chief Executive Officer
SellThu May 14
Olsen Ulrik Kdirector
SellThu Apr 30
Taylor Mark Andrew10 percent owner
SellMon Mar 30
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
1.57
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.